Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
PEPG
PEPG
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PEPG News
PepGen Faces FDA Clinical Hold Investigation
4d ago
Globenewswire
PepGen Shares Drop After FDA Partially Halts Clinical Trial
5d ago
seekingalpha
Veeva Systems Reports Strong Q4 Results and Raises FY27 Guidance
5d ago
Benzinga
PepGen Reports Q4 2025 Earnings Beat with Strong Cash Position
5d ago
seekingalpha
PepGen Faces FDA Partial Hold on FREEDOM2 Trial Amid Regulatory Concerns
5d ago
Benzinga
PepGen Appoints New Chief Business Officer with 160,000 Stock Options Grant
Dec 09 2025
Newsfilter
Meihua International Medical Technologies, Fly-E Group, and Other Major Stocks Decline in Pre-Market Trading on Monday
Dec 08 2025
Benzinga
PepGen Appoints Joseph Vittiglio as Chief Business and Legal Officer
Dec 08 2025
Newsfilter
Sarepta's Shares Climb Following Encouraging News on DM1 Treatment
Nov 25 2025
NASDAQ.COM
PepGen (PEPG) Price Target Raised by 17.65% to $10.20
Nov 17 2025
NASDAQ.COM
Dyne and PepGen Surge as Likely Winners from Novartis/Avidity Agreement
Oct 27 2025
SeekingAlpha
PepGen Unveils Oral Presentations at the 30th Annual World Muscle Society International Congress
Oct 02 2025
Newsfilter
Biotech Stocks Recover in After-Hours Trading Driven by Positive Sector Trends
Oct 01 2025
NASDAQ.COM
Wedbush Keeps Outperform Rating for PepGen, Reduces Price Target to $8
Sep 30 2025
Benzinga
PepGen Secures $115 Million Through Public Offering
Sep 26 2025
Yahoo Finance
PepGen Completes Underwritten Public Offering of Common Stock and Full Exercise of Underwriters' Option for Additional Shares
Sep 26 2025
Newsfilter
Show More News
